COVID-19 Impact on Global In-vitro Toxicity Testing Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-in-vitro-toxicity-testing-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global In-vitro Toxicity Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In-vitro Toxicity Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- CELTHER POLSKA Sp z o.o.
- Charles River Laboratories International Inc.
- Eurofins GSC Lux Sarl
- Evotec AG
- General Electric Co.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Static Well Plate System
- Multi-compartmental Perfused Systems
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global In-vitro Toxicity Testing status, future forecast, growth opportunity, key market and key players.
- To present the In-vitro Toxicity Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In-vitro Toxicity Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Static Well Plate System
1.4.3 Multi-compartmental Perfused Systems
1.5 Market by Application
1.5.1 Global In-vitro Toxicity Testing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical and Biotechnology Companies
1.5.3 Academic and Research Institutions
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): In-vitro Toxicity Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the In-vitro Toxicity Testing Industry
1.6.1.1 In-vitro Toxicity Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and In-vitro Toxicity Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for In-vitro Toxicity Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 In-vitro Toxicity Testing Market Perspective (2015-2026)
2.2 In-vitro Toxicity Testing Growth Trends by Regions
2.2.1 In-vitro Toxicity Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In-vitro Toxicity Testing Historic Market Share by Regions (2015-2020)
2.2.3 In-vitro Toxicity Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 In-vitro Toxicity Testing Market Growth Strategy
2.3.6 Primary Interviews with Key In-vitro Toxicity Testing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top In-vitro Toxicity Testing Players by Market Size
3.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2015-2020)
3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In-vitro Toxicity Testing Market Concentration Ratio
3.2.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2019
3.3 In-vitro Toxicity Testing Key Players Head office and Area Served
3.4 Key Players In-vitro Toxicity Testing Product Solution and Service
3.5 Date of Enter into In-vitro Toxicity Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2015-2020)
4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2021-2026)
5 IN-VITRO TOXICITY TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global In-vitro Toxicity Testing Market Size by Application (2015-2020)
5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America In-vitro Toxicity Testing Market Size (2015-2020)
6.2 In-vitro Toxicity Testing Key Players in North America (2019-2020)
6.3 North America In-vitro Toxicity Testing Market Size by Type (2015-2020)
6.4 North America In-vitro Toxicity Testing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe In-vitro Toxicity Testing Market Size (2015-2020)
7.2 In-vitro Toxicity Testing Key Players in Europe (2019-2020)
7.3 Europe In-vitro Toxicity Testing Market Size by Type (2015-2020)
7.4 Europe In-vitro Toxicity Testing Market Size by Application (2015-2020)
8 CHINA
8.1 China In-vitro Toxicity Testing Market Size (2015-2020)
8.2 In-vitro Toxicity Testing Key Players in China (2019-2020)
8.3 China In-vitro Toxicity Testing Market Size by Type (2015-2020)
8.4 China In-vitro Toxicity Testing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan In-vitro Toxicity Testing Market Size (2015-2020)
9.2 In-vitro Toxicity Testing Key Players in Japan (2019-2020)
9.3 Japan In-vitro Toxicity Testing Market Size by Type (2015-2020)
9.4 Japan In-vitro Toxicity Testing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia In-vitro Toxicity Testing Market Size (2015-2020)
10.2 In-vitro Toxicity Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In-vitro Toxicity Testing Market Size by Type (2015-2020)
10.4 Southeast Asia In-vitro Toxicity Testing Market Size by Application (2015-2020)
11 INDIA
11.1 India In-vitro Toxicity Testing Market Size (2015-2020)
11.2 In-vitro Toxicity Testing Key Players in India (2019-2020)
11.3 India In-vitro Toxicity Testing Market Size by Type (2015-2020)
11.4 India In-vitro Toxicity Testing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America In-vitro Toxicity Testing Market Size (2015-2020)
12.2 In-vitro Toxicity Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America In-vitro Toxicity Testing Market Size by Type (2015-2020)
12.4 Central & South America In-vitro Toxicity Testing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories In-vitro Toxicity Testing Introduction
13.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agilent Technologies Inc.
13.2.1 Agilent Technologies Inc. Company Details
13.2.2 Agilent Technologies Inc. Business Overview and Its Total Revenue
13.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Introduction
13.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.2.5 Agilent Technologies Inc. Recent Development
13.3 Bio-Rad Laboratories Inc.
13.3.1 Bio-Rad Laboratories Inc. Company Details
13.3.2 Bio-Rad Laboratories Inc. Business Overview and Its Total Revenue
13.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Introduction
13.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.3.5 Bio-Rad Laboratories Inc. Recent Development
13.4 CELTHER POLSKA Sp z o.o.
13.4.1 CELTHER POLSKA Sp z o.o. Company Details
13.4.2 CELTHER POLSKA Sp z o.o. Business Overview and Its Total Revenue
13.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Introduction
13.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.4.5 CELTHER POLSKA Sp z o.o. Recent Development
13.5 Charles River Laboratories International Inc.
13.5.1 Charles River Laboratories International Inc. Company Details
13.5.2 Charles River Laboratories International Inc. Business Overview and Its Total Revenue
13.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Introduction
13.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.5.5 Charles River Laboratories International Inc. Recent Development
13.6 Eurofins GSC Lux Sarl
13.6.1 Eurofins GSC Lux Sarl Company Details
13.6.2 Eurofins GSC Lux Sarl Business Overview and Its Total Revenue
13.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Introduction
13.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.6.5 Eurofins GSC Lux Sarl Recent Development
13.7 Evotec AG
13.7.1 Evotec AG Company Details
13.7.2 Evotec AG Business Overview and Its Total Revenue
13.7.3 Evotec AG In-vitro Toxicity Testing Introduction
13.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.7.5 Evotec AG Recent Development
13.8 General Electric Co.
13.8.1 General Electric Co. Company Details
13.8.2 General Electric Co. Business Overview and Its Total Revenue
13.8.3 General Electric Co. In-vitro Toxicity Testing Introduction
13.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.8.5 General Electric Co. Recent Development
13.9 Merck KGaA
13.9.1 Merck KGaA Company Details
13.9.2 Merck KGaA Business Overview and Its Total Revenue
13.9.3 Merck KGaA In-vitro Toxicity Testing Introduction
13.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.9.5 Merck KGaA Recent Development
13.10 Thermo Fisher Scientific Inc.
13.10.1 Thermo Fisher Scientific Inc. Company Details
13.10.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
13.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Introduction
13.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.10.5 Thermo Fisher Scientific Inc. Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In-vitro Toxicity Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Static Well Plate System
1.4.3 Multi-compartmental Perfused Systems
1.5 Market by Application
1.5.1 Global In-vitro Toxicity Testing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical and Biotechnology Companies
1.5.3 Academic and Research Institutions
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): In-vitro Toxicity Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the In-vitro Toxicity Testing Industry
1.6.1.1 In-vitro Toxicity Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and In-vitro Toxicity Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for In-vitro Toxicity Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 In-vitro Toxicity Testing Market Perspective (2015-2026)
2.2 In-vitro Toxicity Testing Growth Trends by Regions
2.2.1 In-vitro Toxicity Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In-vitro Toxicity Testing Historic Market Share by Regions (2015-2020)
2.2.3 In-vitro Toxicity Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 In-vitro Toxicity Testing Market Growth Strategy
2.3.6 Primary Interviews with Key In-vitro Toxicity Testing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top In-vitro Toxicity Testing Players by Market Size
3.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2015-2020)
3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In-vitro Toxicity Testing Market Concentration Ratio
3.2.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2019
3.3 In-vitro Toxicity Testing Key Players Head office and Area Served
3.4 Key Players In-vitro Toxicity Testing Product Solution and Service
3.5 Date of Enter into In-vitro Toxicity Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2015-2020)
4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2021-2026)
5 IN-VITRO TOXICITY TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global In-vitro Toxicity Testing Market Size by Application (2015-2020)
5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America In-vitro Toxicity Testing Market Size (2015-2020)
6.2 In-vitro Toxicity Testing Key Players in North America (2019-2020)
6.3 North America In-vitro Toxicity Testing Market Size by Type (2015-2020)
6.4 North America In-vitro Toxicity Testing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe In-vitro Toxicity Testing Market Size (2015-2020)
7.2 In-vitro Toxicity Testing Key Players in Europe (2019-2020)
7.3 Europe In-vitro Toxicity Testing Market Size by Type (2015-2020)
7.4 Europe In-vitro Toxicity Testing Market Size by Application (2015-2020)
8 CHINA
8.1 China In-vitro Toxicity Testing Market Size (2015-2020)
8.2 In-vitro Toxicity Testing Key Players in China (2019-2020)
8.3 China In-vitro Toxicity Testing Market Size by Type (2015-2020)
8.4 China In-vitro Toxicity Testing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan In-vitro Toxicity Testing Market Size (2015-2020)
9.2 In-vitro Toxicity Testing Key Players in Japan (2019-2020)
9.3 Japan In-vitro Toxicity Testing Market Size by Type (2015-2020)
9.4 Japan In-vitro Toxicity Testing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia In-vitro Toxicity Testing Market Size (2015-2020)
10.2 In-vitro Toxicity Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In-vitro Toxicity Testing Market Size by Type (2015-2020)
10.4 Southeast Asia In-vitro Toxicity Testing Market Size by Application (2015-2020)
11 INDIA
11.1 India In-vitro Toxicity Testing Market Size (2015-2020)
11.2 In-vitro Toxicity Testing Key Players in India (2019-2020)
11.3 India In-vitro Toxicity Testing Market Size by Type (2015-2020)
11.4 India In-vitro Toxicity Testing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America In-vitro Toxicity Testing Market Size (2015-2020)
12.2 In-vitro Toxicity Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America In-vitro Toxicity Testing Market Size by Type (2015-2020)
12.4 Central & South America In-vitro Toxicity Testing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories In-vitro Toxicity Testing Introduction
13.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agilent Technologies Inc.
13.2.1 Agilent Technologies Inc. Company Details
13.2.2 Agilent Technologies Inc. Business Overview and Its Total Revenue
13.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Introduction
13.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.2.5 Agilent Technologies Inc. Recent Development
13.3 Bio-Rad Laboratories Inc.
13.3.1 Bio-Rad Laboratories Inc. Company Details
13.3.2 Bio-Rad Laboratories Inc. Business Overview and Its Total Revenue
13.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Introduction
13.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.3.5 Bio-Rad Laboratories Inc. Recent Development
13.4 CELTHER POLSKA Sp z o.o.
13.4.1 CELTHER POLSKA Sp z o.o. Company Details
13.4.2 CELTHER POLSKA Sp z o.o. Business Overview and Its Total Revenue
13.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Introduction
13.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.4.5 CELTHER POLSKA Sp z o.o. Recent Development
13.5 Charles River Laboratories International Inc.
13.5.1 Charles River Laboratories International Inc. Company Details
13.5.2 Charles River Laboratories International Inc. Business Overview and Its Total Revenue
13.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Introduction
13.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.5.5 Charles River Laboratories International Inc. Recent Development
13.6 Eurofins GSC Lux Sarl
13.6.1 Eurofins GSC Lux Sarl Company Details
13.6.2 Eurofins GSC Lux Sarl Business Overview and Its Total Revenue
13.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Introduction
13.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.6.5 Eurofins GSC Lux Sarl Recent Development
13.7 Evotec AG
13.7.1 Evotec AG Company Details
13.7.2 Evotec AG Business Overview and Its Total Revenue
13.7.3 Evotec AG In-vitro Toxicity Testing Introduction
13.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.7.5 Evotec AG Recent Development
13.8 General Electric Co.
13.8.1 General Electric Co. Company Details
13.8.2 General Electric Co. Business Overview and Its Total Revenue
13.8.3 General Electric Co. In-vitro Toxicity Testing Introduction
13.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.8.5 General Electric Co. Recent Development
13.9 Merck KGaA
13.9.1 Merck KGaA Company Details
13.9.2 Merck KGaA Business Overview and Its Total Revenue
13.9.3 Merck KGaA In-vitro Toxicity Testing Introduction
13.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.9.5 Merck KGaA Recent Development
13.10 Thermo Fisher Scientific Inc.
13.10.1 Thermo Fisher Scientific Inc. Company Details
13.10.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
13.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Introduction
13.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020)
13.10.5 Thermo Fisher Scientific Inc. Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. In-vitro Toxicity Testing Key Market Segments
Table 2. Key Players Covered: Ranking by In-vitro Toxicity Testing Revenue
Table 3. Ranking of Global Top In-vitro Toxicity Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Static Well Plate System
Table 6. Key Players of Multi-compartmental Perfused Systems
Table 7. COVID-19 Impact Global Market: (Four In-vitro Toxicity Testing Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for In-vitro Toxicity Testing Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for In-vitro Toxicity Testing Players to Combat Covid-19 Impact
Table 12. Global In-vitro Toxicity Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global In-vitro Toxicity Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global In-vitro Toxicity Testing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global In-vitro Toxicity Testing Market Share by Regions (2015-2020)
Table 16. Global In-vitro Toxicity Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global In-vitro Toxicity Testing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. In-vitro Toxicity Testing Market Growth Strategy
Table 22. Main Points Interviewed from Key In-vitro Toxicity Testing Players
Table 23. Global In-vitro Toxicity Testing Revenue by Players (2015-2020) (Million US$)
Table 24. Global In-vitro Toxicity Testing Market Share by Players (2015-2020)
Table 25. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2019)
Table 26. Global In-vitro Toxicity Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players In-vitro Toxicity Testing Product Solution and Service
Table 29. Date of Enter into In-vitro Toxicity Testing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 32. Global In-vitro Toxicity Testing Market Size Share by Type (2015-2020)
Table 33. Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2026)
Table 34. Global In-vitro Toxicity Testing Market Size Share by Application (2015-2020)
Table 35. Global In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 36. Global In-vitro Toxicity Testing Market Size Share by Application (2021-2026)
Table 37. North America Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 39. North America In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 40. North America In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 41. North America In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 42. North America In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 43. Europe Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 45. Europe In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 47. Europe In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 49. China Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 50. China Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 51. China In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 52. China In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 53. China In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 54. China In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 55. Japan Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 57. Japan In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 59. Japan In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 63. Southeast Asia In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 65. Southeast Asia In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 67. India Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 68. India Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 69. India In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 70. India In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 71. India In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 72. India In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 75. Central & South America In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 77. Central & South America In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Product
Table 82. Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 83. Abbott Laboratories Recent Development
Table 84. Agilent Technologies Inc. Company Details
Table 85. Agilent Technologies Inc. Business Overview
Table 86. Agilent Technologies Inc. Product
Table 87. Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 88. Agilent Technologies Inc. Recent Development
Table 89. Bio-Rad Laboratories Inc. Company Details
Table 90. Bio-Rad Laboratories Inc. Business Overview
Table 91. Bio-Rad Laboratories Inc. Product
Table 92. Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 93. Bio-Rad Laboratories Inc. Recent Development
Table 94. CELTHER POLSKA Sp z o.o. Company Details
Table 95. CELTHER POLSKA Sp z o.o. Business Overview
Table 96. CELTHER POLSKA Sp z o.o. Product
Table 97. CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 98. CELTHER POLSKA Sp z o.o. Recent Development
Table 99. Charles River Laboratories International Inc. Company Details
Table 100. Charles River Laboratories International Inc. Business Overview
Table 101. Charles River Laboratories International Inc. Product
Table 102. Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 103. Charles River Laboratories International Inc. Recent Development
Table 104. Eurofins GSC Lux Sarl Company Details
Table 105. Eurofins GSC Lux Sarl Business Overview
Table 106. Eurofins GSC Lux Sarl Product
Table 107. Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 108. Eurofins GSC Lux Sarl Recent Development
Table 109. Evotec AG Company Details
Table 110. Evotec AG Business Overview
Table 111. Evotec AG Product
Table 112. Evotec AG Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 113. Evotec AG Recent Development
Table 114. General Electric Co. Business Overview
Table 115. General Electric Co. Product
Table 116. General Electric Co. Company Details
Table 117. General Electric Co. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 118. General Electric Co. Recent Development
Table 119. Merck KGaA Company Details
Table 120. Merck KGaA Business Overview
Table 121. Merck KGaA Product
Table 122. Merck KGaA Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 123. Merck KGaA Recent Development
Table 124. Thermo Fisher Scientific Inc. Company Details
Table 125. Thermo Fisher Scientific Inc. Business Overview
Table 126. Thermo Fisher Scientific Inc. Product
Table 127. Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 128. Thermo Fisher Scientific Inc. Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. In-vitro Toxicity Testing Key Market Segments
Table 2. Key Players Covered: Ranking by In-vitro Toxicity Testing Revenue
Table 3. Ranking of Global Top In-vitro Toxicity Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Static Well Plate System
Table 6. Key Players of Multi-compartmental Perfused Systems
Table 7. COVID-19 Impact Global Market: (Four In-vitro Toxicity Testing Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for In-vitro Toxicity Testing Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for In-vitro Toxicity Testing Players to Combat Covid-19 Impact
Table 12. Global In-vitro Toxicity Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global In-vitro Toxicity Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global In-vitro Toxicity Testing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global In-vitro Toxicity Testing Market Share by Regions (2015-2020)
Table 16. Global In-vitro Toxicity Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global In-vitro Toxicity Testing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. In-vitro Toxicity Testing Market Growth Strategy
Table 22. Main Points Interviewed from Key In-vitro Toxicity Testing Players
Table 23. Global In-vitro Toxicity Testing Revenue by Players (2015-2020) (Million US$)
Table 24. Global In-vitro Toxicity Testing Market Share by Players (2015-2020)
Table 25. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2019)
Table 26. Global In-vitro Toxicity Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players In-vitro Toxicity Testing Product Solution and Service
Table 29. Date of Enter into In-vitro Toxicity Testing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 32. Global In-vitro Toxicity Testing Market Size Share by Type (2015-2020)
Table 33. Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2026)
Table 34. Global In-vitro Toxicity Testing Market Size Share by Application (2015-2020)
Table 35. Global In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 36. Global In-vitro Toxicity Testing Market Size Share by Application (2021-2026)
Table 37. North America Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 39. North America In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 40. North America In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 41. North America In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 42. North America In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 43. Europe Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 45. Europe In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 47. Europe In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 49. China Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 50. China Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 51. China In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 52. China In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 53. China In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 54. China In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 55. Japan Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 57. Japan In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 59. Japan In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 63. Southeast Asia In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 65. Southeast Asia In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 67. India Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 68. India Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 69. India In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 70. India In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 71. India In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 72. India In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players In-vitro Toxicity Testing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players In-vitro Toxicity Testing Market Share (2019-2020)
Table 75. Central & South America In-vitro Toxicity Testing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America In-vitro Toxicity Testing Market Share by Type (2015-2020)
Table 77. Central & South America In-vitro Toxicity Testing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America In-vitro Toxicity Testing Market Share by Application (2015-2020)
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Product
Table 82. Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 83. Abbott Laboratories Recent Development
Table 84. Agilent Technologies Inc. Company Details
Table 85. Agilent Technologies Inc. Business Overview
Table 86. Agilent Technologies Inc. Product
Table 87. Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 88. Agilent Technologies Inc. Recent Development
Table 89. Bio-Rad Laboratories Inc. Company Details
Table 90. Bio-Rad Laboratories Inc. Business Overview
Table 91. Bio-Rad Laboratories Inc. Product
Table 92. Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 93. Bio-Rad Laboratories Inc. Recent Development
Table 94. CELTHER POLSKA Sp z o.o. Company Details
Table 95. CELTHER POLSKA Sp z o.o. Business Overview
Table 96. CELTHER POLSKA Sp z o.o. Product
Table 97. CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 98. CELTHER POLSKA Sp z o.o. Recent Development
Table 99. Charles River Laboratories International Inc. Company Details
Table 100. Charles River Laboratories International Inc. Business Overview
Table 101. Charles River Laboratories International Inc. Product
Table 102. Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 103. Charles River Laboratories International Inc. Recent Development
Table 104. Eurofins GSC Lux Sarl Company Details
Table 105. Eurofins GSC Lux Sarl Business Overview
Table 106. Eurofins GSC Lux Sarl Product
Table 107. Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 108. Eurofins GSC Lux Sarl Recent Development
Table 109. Evotec AG Company Details
Table 110. Evotec AG Business Overview
Table 111. Evotec AG Product
Table 112. Evotec AG Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 113. Evotec AG Recent Development
Table 114. General Electric Co. Business Overview
Table 115. General Electric Co. Product
Table 116. General Electric Co. Company Details
Table 117. General Electric Co. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 118. General Electric Co. Recent Development
Table 119. Merck KGaA Company Details
Table 120. Merck KGaA Business Overview
Table 121. Merck KGaA Product
Table 122. Merck KGaA Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 123. Merck KGaA Recent Development
Table 124. Thermo Fisher Scientific Inc. Company Details
Table 125. Thermo Fisher Scientific Inc. Business Overview
Table 126. Thermo Fisher Scientific Inc. Product
Table 127. Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2015-2020) (Million US$)
Table 128. Thermo Fisher Scientific Inc. Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global In-vitro Toxicity Testing Market Share by Type: 2020 VS 2026
Figure 2. Static Well Plate System Features
Figure 3. Multi-compartmental Perfused Systems Features
Figure 4. Global In-vitro Toxicity Testing Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical and Biotechnology Companies Case Studies
Figure 6. Academic and Research Institutions Case Studies
Figure 7. Others Case Studies
Figure 8. In-vitro Toxicity Testing Report Years Considered
Figure 9. Global In-vitro Toxicity Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global In-vitro Toxicity Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global In-vitro Toxicity Testing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global In-vitro Toxicity Testing Market Share by Players in 2019
Figure 14. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by In-vitro Toxicity Testing Revenue in 2019
Figure 16. North America In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Laboratories Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 25. Agilent Technologies Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Agilent Technologies Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 27. Bio-Rad Laboratories Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bio-Rad Laboratories Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 29. CELTHER POLSKA Sp z o.o. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. CELTHER POLSKA Sp z o.o. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 31. Charles River Laboratories International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Charles River Laboratories International Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 33. Eurofins GSC Lux Sarl Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eurofins GSC Lux Sarl Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 35. Evotec AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Evotec AG Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 37. General Electric Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. General Electric Co. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 39. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck KGaA Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 41. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Thermo Fisher Scientific Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Figure 1. Global In-vitro Toxicity Testing Market Share by Type: 2020 VS 2026
Figure 2. Static Well Plate System Features
Figure 3. Multi-compartmental Perfused Systems Features
Figure 4. Global In-vitro Toxicity Testing Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical and Biotechnology Companies Case Studies
Figure 6. Academic and Research Institutions Case Studies
Figure 7. Others Case Studies
Figure 8. In-vitro Toxicity Testing Report Years Considered
Figure 9. Global In-vitro Toxicity Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global In-vitro Toxicity Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global In-vitro Toxicity Testing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global In-vitro Toxicity Testing Market Share by Players in 2019
Figure 14. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by In-vitro Toxicity Testing Revenue in 2019
Figure 16. North America In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America In-vitro Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Laboratories Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 25. Agilent Technologies Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Agilent Technologies Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 27. Bio-Rad Laboratories Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bio-Rad Laboratories Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 29. CELTHER POLSKA Sp z o.o. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. CELTHER POLSKA Sp z o.o. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 31. Charles River Laboratories International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Charles River Laboratories International Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 33. Eurofins GSC Lux Sarl Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eurofins GSC Lux Sarl Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 35. Evotec AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Evotec AG Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 37. General Electric Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. General Electric Co. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 39. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck KGaA Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 41. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Thermo Fisher Scientific Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed